| NCT Number | NCT07488897 |
| Lead Sponsor | RIGImmune Inc.
Collaborators: Virtus Respiratory Research, Medicines Evaluation Unit Ltd |
| Conditions | Healthy Adult Participants, Asthma Exacerbation, Safety and Efficacy |
| Enrollment | 82 participants |
| Start Date | 2026-02-09 |
| Primary Completion | 2027-02 (estimated) |
| Study Completion | 2027-02 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-23 |